618 related articles for article (PubMed ID: 12374680)
1. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
3. Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma.
Ikeguchi M; Ueda T; Sakatani T; Hirooka Y; Kaibara N
Diagn Mol Pathol; 2002 Mar; 11(1):33-40. PubMed ID: 11854600
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.
Ikeguchi M; Hirooka Y
Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488
[TBL] [Abstract][Full Text] [Related]
5. In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.
Takashima H; Nakajima T; Moriguchi M; Sekoguchi S; Nishikawa T; Watanabe T; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
Liver Int; 2005 Feb; 25(1):77-84. PubMed ID: 15698402
[TBL] [Abstract][Full Text] [Related]
6. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736
[TBL] [Abstract][Full Text] [Related]
7. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
Bao ST; Gui SQ; Lin MS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
[TBL] [Abstract][Full Text] [Related]
8. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma.
Chau GY; Lee AF; Tsay SH; Ke YR; Kao HL; Wong FH; Tsou AP; Chau YP
Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540
[TBL] [Abstract][Full Text] [Related]
10. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
[TBL] [Abstract][Full Text] [Related]
11. Survivin promotes cell proliferation in human hepatocellular carcinoma.
Ito T; Shiraki K; Sugimoto K; Yamanaka T; Fujikawa K; Ito M; Takase K; Moriyama M; Kawano H; Hayashida M; Nakano T; Suzuki A
Hepatology; 2000 May; 31(5):1080-5. PubMed ID: 10796883
[TBL] [Abstract][Full Text] [Related]
12. Effect of survivin on cell proliferation and apoptosis in gastric cancer.
Wakana Y; Kasuya K; Katayanagi S; Tsuchida A; Aoki T; Koyanagi Y; Ishii H; Ebihara Y
Oncol Rep; 2002; 9(6):1213-8. PubMed ID: 12375022
[TBL] [Abstract][Full Text] [Related]
13. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
Ikeguchi M; Kaibara N
Br J Cancer; 2002 Oct; 87(8):883-7. PubMed ID: 12373603
[TBL] [Abstract][Full Text] [Related]
14. Expression of inducible nitric oxide synthase during cisplatin-based chemotherapy for gastric cancer.
Ikeguchi M; Ueta T; Kaibara N
In Vivo; 2002; 16(3):185-90. PubMed ID: 12182114
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma.
Cho S; Lee JH; Cho SB; Yoon KW; Park SY; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
Pathol Int; 2010 Mar; 60(3):203-11. PubMed ID: 20403046
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
Augello C; Caruso L; Maggioni M; Donadon M; Montorsi M; Santambrogio R; Torzilli G; Vaira V; Pellegrini C; Roncalli M; Coggi G; Bosari S
BMC Cancer; 2009 Apr; 9():125. PubMed ID: 19397802
[TBL] [Abstract][Full Text] [Related]
17. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.
Fetz V; Bier C; Habtemichael N; Schuon R; Schweitzer A; Kunkel M; Engels K; Kovács AF; Schneider S; Mann W; Stauber RH; Knauer SK
Int J Cancer; 2009 May; 124(9):2033-41. PubMed ID: 19130609
[TBL] [Abstract][Full Text] [Related]
18. Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis.
Kishi H; Igawa M; Kikuno N; Yoshino T; Urakami S; Shiina H
J Urol; 2004 May; 171(5):1855-60. PubMed ID: 15076293
[TBL] [Abstract][Full Text] [Related]
19. Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth?
Moon WS; Tarnawski AS
Hum Pathol; 2003 Nov; 34(11):1119-26. PubMed ID: 14652813
[TBL] [Abstract][Full Text] [Related]
20. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ
Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
